Gainers
- Silexion Therapeutics SLXN stock increased by 112.1% to $1.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.9 million.
- IMAC Hldgs BACK stock increased by 62.84% to $1.35. The company's market cap stands at $2.7 million.
- Trinity Biotech TRIB shares rose 61.86% to $1.23. The market value of their outstanding shares is at $33.8 million.
- Hepion Pharmaceuticals HEPA stock rose 32.84% to $0.22. The market value of their outstanding shares is at $1.5 million.
- Surgery Partners SGRY stock increased by 19.85% to $25.47. The market value of their outstanding shares is at $3.2 billion.
- Palatin Techs PTN shares rose 13.78% to $0.99. The market value of their outstanding shares is at $23.2 million.
Losers
- Sharps Technology STSS stock decreased by 69.2% to $0.45 during Tuesday's pre-market session.
- Leap Therapeutics LPTX shares fell 63.54% to $0.82. The market value of their outstanding shares is at $31.4 million.
- SAB Biotherapeutics SABS shares declined by 44.73% to $2.41. The market value of their outstanding shares is at $22.2 million.
- Akoya Biosciences AKYA shares declined by 20.78% to $2.44. The market value of their outstanding shares is at $120.9 million.
- Onconetix ONCO shares fell 16.71% to $0.54. The market value of their outstanding shares is at $4.4 million.
- Tevogen Bio Holdings TVGN shares declined by 12.5% to $1.47. The market value of their outstanding shares is at $257.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BACKIMAC Holdings Inc
$0.7400-39.3%
HEPAHepion Pharmaceuticals Inc
$0.1754-21.2%
LPTXLeap Therapeutics Inc
$0.5678-12.7%
ONCOOnconetix Inc
$0.5844-2.60%
PTNPalatin Technologies Inc
$0.95946.27%
SABSSAB Biotherapeutics Inc
$2.258.70%
SGRYSurgery Partners Inc
$25.75-%
SLXNSilexion Therapeutics Corp
$3.12131.1%
STSSSharps Technology Inc
$0.3775-19.1%
TRIBTrinity Biotech PLC
$1.35-0.74%
TVGNTevogen Bio Holdings Inc
$1.45-5.24%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in